On this episode of MesoTV, our Patient Services Director, Julie White, sits down with Melissa Culligan, PhD, RN. Melissa is the Director of Thoracic Surgery Research at Temple University Hospital and the Co-Director of the Temple Health Mesothelioma and Pleural Disease Program. She goes through the details of thoracic surgery…
On this episode of MesoTV, join our Patient Services Director, Julie White, as she speaks with Marjorie Zauderer, MD, MS, FACP, and Lee Krug, MD, about the eVOLVE meso clinical trial for patients with pleural mesothelioma. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made…
Surgery is vital option for treatment for many patients with pleural mesothelioma. This session discusses how pleural surgery works and why it is an option for some patients. This session is presented by:Chuong Hoang, MD, National Cancer Institute This is a recording of a session at the 2024 International Symposium on…
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with pemetrexed and platinum-based chemotherapy. Keytruda(pembrolizumab) is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body’s immune system to help…
In this episode of MesoTV, three patients, two with peritoneal mesothelioma and one with pleural mesothelioma, tell their stories of diagnosis, treatment, subsequent recurrence, and…
The Meso Foundation’s International Symposium on Malignant Mesothelioma is a unique conference that brings together the entire mesothelioma community. We invite patients, their families, caregivers,…
Due to recent advances in cancer treatment, especially in the field of immunotherapy, chemotherapy treatment options for mesothelioma have taken a back seat. However, this…
Watch the video of experts in the field of pleural mesothelioma as they discuss pleural mesothelioma treatments, surgery, clinical trials, and case studies.A unique session focusing on a multidisciplinary approach to the treatment of pleural mesothelioma. The session features a pulmonologist, three mesothelioma surgeons, and a medical oncologist who specializes in mesothelioma…
Dr. Wolf is interviewed by Shannon Sinclair, RN, BSN, OCN, who serves as the patient services director at the Mesothelioma Applied Research Foundation. www.curemeso.org. In…
Separately, chemotherapy and immunotherapy are both approved to treat mesothelioma, and individually they work equally well for those patients with the epithelioid type of disease.…